Skip to main content

2020 Awardees

Learn more about the 2020 NFID Award recipients and read their perspectives on what they see as the biggest challenges and opportunities in infectious diseases.

Penny Heaton

Penny M. Heaton, MD, Jimmy and Rosalynn Carter Humanitarian Award

The Jimmy and Rosalynn Carter Humanitarian Award honors individuals whose outstanding humanitarian efforts and achievements have contributed significantly to improving global public health. Dr. Heaton is renowned for leading the development of vaccines that have saved millions of lives, including vaccines for rotavirus, influenza, and meningococcal disease. Her groundbreaking research and development contributions on group B Streptococcus have addressed important causes of prematurity, stillbirths, and neonatal sepsis.

 

 

Claire Broome

Claire V. Broome, MD, Maxwell Finland Award for Scientific Achievement

The Maxwell Finland Award for Scientific Achievement honors scientists who have made outstanding contributions to the understanding of infectious diseases and public health. Dr. Broome has had a profound influence on global vaccine policy-making, including advising the World Health Organization and other organizations on vaccines, disease burden and surveillance, and outbreak detection and response. Her conceptualization and use of the “indirect cohort” approach to measuring the effectiveness of pneumococcal polysaccharide vaccine has become a landmark in observational studies of vaccines.

 

 

Richard Whitley

Richard J. Whitley, MD, John P. Utz Leadership Award

The John P. Utz Leadership Award honors individuals who exemplify and support NFID leadership goals, through service to NFID and/or the field of infectious diseases. Dr. Whitley is recognized for his long-standing leadership in the field of clinical virology and his expertise in how antiviral therapies fight infections in children and adults. Best known for his pioneering work in herpes antivirals, he also led the development of guidelines for the emergency use of influenza antiviral therapy in infants.